The American Committee for the Weizmann Institute of Science has announced a $50 million commitment from Nancy and Stephen Grand to advance the international study of personalized medicine.
The gift will support the recently established Israel National Center for Personalized Medicine at the Weizmann Institute in Rehovot, Israel, a state-of-the-art biomedical research center focused on the fields of genomics, protein profiling, bioinformatics, and drug discovery. In recognition of the largest contribution ever to the American Committee for the Weizmann Institute of Science, the center has been renamed after the couple.
The grant to the center, which supports research conducted in Israel's universities, hospitals, and life sciences, pharmaceutical, biotechnology, and biomedical industries, will enable it to collaborate with researchers from leading institutions abroad, offering the advantage of drawing on Israel's diverse genetic pool representing populations from around the globe.
"Nancy and I recognize that Israel is a world leader in science and technology," said Stephen Grand, co-founder of Grand/Sakwa Properties and former president and owner of Deco-Grand. "This gift enables Weizmann to equip itself to participate in the exploding world of genetics and to find cures for diseases to improve the human condition. We all know that the brilliance of Weizmann's scientists will result in major progress from which we will all benefit."